✦ LIBER ✦

Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

✍ Scribed by Mary-Ellen Taplin; Daniel J. George; Susan Halabi; Ben Sanford; Philip G. Febbo; Kristen T. Hennessy; Christos G. Mihos; Nicholas J. Vogelzang; Eric J. Small; Philip W. Kantoff

Book ID: 116945036
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 122 KB
Volume: 66
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2005.03.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LB22 Prognostic role of plasma chromogra

LB22 Prognostic role of plasma chromogranin a levels in prostate cancer patients with hormone refractory disease

✍ C. Terrone; R. Tarabuzzi; C. Cracco; S. Guercio; M. Poggio; C. Scoffone; F. Porp 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Testosterone levels in patients with met

Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?

✍ Massimo Perachino; Valerio Cavalli; Fabio Bravi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Leukoerythroblastic anemia in metastatic

Leukoerythroblastic anemia in metastatic prostate cancer. Clinical and prognostic significance in patients with hormone-refractory disease

✍ Glenn J. Shamdas; Frederick R. Ahmann; Monika B. Matzner; Justine M. Ritchie 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

A Phase II Study of Estramustine, Doceta

A Phase II Study of Estramustine, Docetaxel, and Exisulind in Patients with Hormone- Refractory Prostate Cancer: Results of Cancer and Leukemia Group B Trial 90004

✍ Nancy A. Dawson; Susan Halabi; San-San Ou; David D. Biggs; Anne Kessinger; Nicho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 130 KB

Higher doses of mitoxantrone among men w

Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma : A Cancer and Leukemia Group B study

✍ Ellis G. Levine; Susan Halabi; John D. Roberts; Ellen B. Kaplan; Randall Rago; J 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Quality of life impact of three differen

Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma : Results of Intergroup 0159/Cancer and Leukemia Group B 9480

✍ Tim A. Ahles; James E. Herndon II; Eric J. Small; Nicholas J. Vogelzang; Alice B 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views